Page History
...
Data Element | Description | ||||||||
---|---|---|---|---|---|---|---|---|---|
NCI ID | The
| ||||||||
Lead Org ID | The
information, refer to Abstracting Trial Descriptions, Titles, and Identifiers. | ||||||||
Title | The
information, refer to Abstracting Trial Descriptions, Titles, and Identifiers. | ||||||||
Lead Organization PO ID | Identifier The unique ID assigned to the lead organization by the CTRP. For more information, refer to Abstracting Trial Descriptions, Titles, and Identifiers. | ||||||||
Lead Organization | The
| ||||||||
NCT ID | The
| ||||||||
CTEP ID | Identifier assigned to this trial by the CTEP (Cancer Therapy Evaluation Program). For more The
| ||||||||
DCP ID | The
| ||||||||
Funding Mechanism | Unique, three-character code for the funding mechanism of a grant on a trial. NIH assigns these codes to areas of extramural research activity. For more information, refer to A
| ||||||||
NCI Division/Program | NCI organizational unit that provides funding for the trial, as The NCI division or program identified in an IND, IDE, or grant record, as the
information, refer | ||||||||
Institution Code | The NIH institution associated with the trial, as identified in an IND, IDE, or grant record. For information, refer to NIH Institution Code Values, NIH Grant Institute Code Values, Abstracting INDs and IDEs, or Abstracting Funding. | ||||||||
IND/IDE GrantorName | The
For information, refer to Abstracting INDs and IDEs. | ||||||||
IND/IDE Holder Type | The
For information, refer to Abstracting INDs and IDEs. | ||||||||
IND/IDE Number | The
| ||||||||
IND/IDE Types | Value indicating whether the trial involves an Investigational New Drug Application (IND) or Investigational Device Exemption (IDE). For more A value indicating
| ||||||||
Section 801 IndicatorValue | indicating whether the FDA-regulated interventional trial is an applicable trial as defined in US Public Law 110-85, Title VIII, Section 801. For more A value indicating
| ||||||||
Principal Investigator | The
| ||||||||
Sponsor Org | The
| ||||||||
Responsible Party | The
| ||||||||
Summary 4 Funding Sponsor | The
information, refer to Abstracting Sponsors and Responsible Parties. | ||||||||
Trial Status | The
| ||||||||
Trial Status Date | The
| ||||||||
Trial Start Date | The
| ||||||||
Primary Completion Date | The
| ||||||||
Primary Completion Date Type | A
| ||||||||
Submitting Org Name | Name The name of the organization that submitted the trial. | ||||||||
Current Processing Status | The
| ||||||||
Study Category | The
| ||||||||
Submission Number | A
information, refer to Processing Trial History Information. | ||||||||
Trial Submission Type | Value indicating whether the trial record is an original submission or an amendment. For more A value indicating
| ||||||||
Trial Summary Report Sent Date | Date The date on which the system sent the Trial Summary Report (TSR) to the principal investigator or trial submitter. For more information, refer to Processing Trial Milestones. |
...
hidden | true |
---|
...
. |